ArticleJournal of maxillofacial and oral surgery2026
Improvement in Survival Rates and Quality of Life Among Patients Surgically Treated for Squamous Cell Carcinoma of the Oral Cavity.
Article in Journal of maxillofacial and oral surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High-Energy Lasers in Oral Oncology: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The study aimed to assess if outcomes for oral squamous cell carcinoma (OSCC) patients have improved, and if so, whether these improvements correlate with changes in diagnostic and therapeutic methods over time. Methods: Retrospective study including patients surgically treated for OSCC between 2002 and 2020. Results: Among the 193 consecutive patients with primary OSCC who met the inclusion criteria (median age 66; 60.4% male), 80 (41.4%) were treated between 2002 and 2011, and 113 (58.6%) between 2011 and 2020. Multivariate analysis showed a significant improvement in overall survival rates from 2012 to 2020, compared with the period from 2002 to 2011 (HR for death, 0.33; 95% CI 0.17-0.67). Similar observations have emerged in progression-free and disease-specific survival. When stratified by stage, the improvement was found to be significant only for advanced stages. The use of NBI during both preoperative and operative setting as well as margin mapping significantly increased over the time. Both patients with early and advanced-stage OSCC treated between 2012 and 2020 exhibited improved pain scores. Conclusions: Despite the shift to less invasive surgeries, our analysis shows significant improvement over time, especially in advanced-stage diseases, highlighting the impact of evolving strategies on challenging cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.